Beyond leukemia, RARα signaling is being explored as a target for solid tumors.
: Activation of RARα has been found to be sufficient for the full induction of retinoid responses in certain human breast cancer cells , suggesting it is a crucial receptor for signaling in these cases. 🧴 Other Applications ALPHA.rar
RARα is a cornerstone in the treatment of . Translocation : A hallmark feature of APL is the translocation, which creates the PML-RARα fusion protein. Beyond leukemia, RARα signaling is being explored as
: It functions as a non-hormonal oral male contraceptive that impairs retinoic acid signaling in the testes to decrease sperm count. Translocation : A hallmark feature of APL is
: This fusion blocks cell differentiation, leading to a build-up of immature cells. Treatment with All-trans retinoic acid (ATRA) —often in combination with arsenic trioxide—can overcome this block and induce complete remission . 🛡️ Cancer Prevention & Therapeutics
: Recent Phase 1a clinical trials published in 2025/2026 show it is safe, well-tolerated, and—most importantly—the sterility it causes is reversible . 🧬 Role in Leukemia (APL)